W. Blake Coblentz

W. Blake Coblentz

W. Blake Coblentz is the co-chair of Cozen O’Connor’s Hatch-Waxman & Biologics Litigation practice and a registered patent attorney. Based in the firm’s Washington D.C. office, he focuses his practice on patent litigation and counseling for clients in the biotechnology and pharmaceutical industries. He counsels pharmaceutical companies in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities.

Posts by W. Blake Coblentz

Hatch-Waxman and BPCIA Cases and Trends to Watch in 2021

As we turn the page to 2021, we expect at least two major cases to be resolved that could have long-lasting effects on where and how Hatch-Waxman and …

The PTAB Puts Hatch-Waxman Defendants on Notice: File IPRs Early or Risk Fintiv Discretionary Denial

On September 16, 2020, the Patent Trial and Appeal Board (PTAB) denied institution of Mylan Labs Ltd.’s petition for IPR of U.S. Patent No. 9,439,906 (“the ’906 patent”) in …